Healthcare stocks advanced 0.3% at midday Tuesday. The Reserve Bank of Australia is expected to announce the anticipated interest rate decision later on the same day.
Opthea (ASX:OPT) completed the final week-52 patient visit in Coast, the first of two phase three trials evaluating a combination therapy candidate for wet age-related macular degeneration, an eye disease that can blur vision.
On the other hand, energy stocks were down 1.7%. Woodside Energy Group (ASX:WDS) extended losses from the Monday trading session, after it implied its final dividend could fall below expectations by as much as 20%.
Woodside held talks with several potential buyers of stakes in its Louisiana liquefied natural gas plant, including Tokyo Gas, Japan's JERA, and MidOcean Energy, Reuters reported citing multiple sources.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。